poisar

Stocks · News reference

Archrock shares are trading lower after the company reported worse-than-expected Q2 financial results.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchZacks.Com

    Is It Worth Investing in Archrock Inc. (AROC) Based on Wall Street's Bullish Views?

    While Wall Street analysts maintain a bullish average brokerage recommendation (ABR) of 1.44 for Archrock Inc. with six Strong Buy and two Buy ratings, the article cautions that brokerage recommendations often have a positive bias and may not reliably predict stock performance. The Zacks Rank system, which is based on earnings estimate revisions, has assigned AROC a Strong Sell rating due to a 9.3% decline in consensus earnings estimates over the past month, suggesting investors should be skeptical of the bullish Wall Street consensus.